D T Curiel - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

D T Curiel

Showing results (151-160 of 255) with videos related to

Pageof 26

Sort By:

International Journal of Cancer|April 3, 2001

Overcoming multi-drug resistance using an intracellular anti-MDR1 sFvY Heike, K Kasono, C Kunisaki, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000

Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitroF J Kelly, C R Miller, D J Buchsbaum, et al.

Gene Therapy|March 5, 2004

A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinomaA Kanerva, G J Bauerschmitz, M Yamamoto, et al.

Nature Biotechnology|November 27, 1998

Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen presenting cellsH G Zhang, D Liu, Y Heike, et al.

Seminars in Oncology|June 20, 1998

Gene therapy for ovarian carcinomaM W Robertson, M N Barnes, C Rancourt, et al.

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 8, 1998

Combined cytosine deaminase expression, 5-fluorocytosine exposure, and radiotherapy increases cytotoxicity to cholangiocarcinoma cellsL C Pederson, S M Vickers, D J Buchsbaum, et al.

The Journal of Gene Medicine|May 16, 2000

Pro-apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancerJ Xiang, J Gómez-Navarro, W Arafat, et al.

Gene Therapy|July 26, 2002

Fiber shaft extension in combination with HI loop ligands augments infectivity for CAR-negative tumor targets but does not enhance hepatotropism in vivoT Seki, I Dmitriev, K Suzuki, et al.

Cancer Research|October 23, 1997

Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivoL C Pederson, D J Buchsbaum, S M Vickers, et al.

Arthritis and Rheumatism|May 19, 2000

Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblastsH G Zhang, N Huang, D Liu, et al.

Pageof 26

Search research articles

Showing results (151-160 of 255) with videos related to

Sort By:

Pageof 26

International Journal of Cancer|April 3, 2001

Overcoming multi-drug resistance using an intracellular anti-MDR1 sFvY Heike, K Kasono, C Kunisaki, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000

Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitroF J Kelly, C R Miller, D J Buchsbaum, et al.

Gene Therapy|March 5, 2004

A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinomaA Kanerva, G J Bauerschmitz, M Yamamoto, et al.

Nature Biotechnology|November 27, 1998

Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen presenting cellsH G Zhang, D Liu, Y Heike, et al.

Seminars in Oncology|June 20, 1998

Gene therapy for ovarian carcinomaM W Robertson, M N Barnes, C Rancourt, et al.

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 8, 1998

Combined cytosine deaminase expression, 5-fluorocytosine exposure, and radiotherapy increases cytotoxicity to cholangiocarcinoma cellsL C Pederson, S M Vickers, D J Buchsbaum, et al.

The Journal of Gene Medicine|May 16, 2000

Pro-apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancerJ Xiang, J Gómez-Navarro, W Arafat, et al.

Gene Therapy|July 26, 2002

Fiber shaft extension in combination with HI loop ligands augments infectivity for CAR-negative tumor targets but does not enhance hepatotropism in vivoT Seki, I Dmitriev, K Suzuki, et al.

Cancer Research|October 23, 1997

Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivoL C Pederson, D J Buchsbaum, S M Vickers, et al.

Arthritis and Rheumatism|May 19, 2000

Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblastsH G Zhang, N Huang, D Liu, et al.

Pageof 26